| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.005 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.089 | 0.005 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.13 | 0.005 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.081 | 0.005 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.13 | 0.005 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.15 | 0.005 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.006 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.14 | 0.006 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.006 |